MYRIAD GENETICS INC — Director's Dealing 2013

Jun 14, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-06-13

Reporting Person: Harrison Robert Gardner (Chief Information Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-13	Common Stock	M	17498	$16.53	Acquired	20593	Direct
2013-06-13	Common Stock	S	17498	$35.093	Disposed	3095	Direct
2013-06-13	Common Stock	M	14000	$19.47	Acquired	17095	Direct
2013-06-13	Common Stock	S	14000	$37.523	Disposed	3095	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-13	Non-Qualified Stock Option (right to buy)	$16.53	M	17498	Disposed	2020-09-15	Common Stock (17498)	Direct
2013-06-13	Non-Qualified Stock Option (right to buy)	$19.47	M	14000	Disposed	2021-09-13	Common Stock (14000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.